116 related articles for article (PubMed ID: 14980636)
1. Synthesis and biological evaluation of novel macrocyclic bis-7-azaindolylmaleimides as potent and highly selective glycogen synthase kinase-3 beta (GSK-3 beta) inhibitors.
Shen L; Prouty C; Conway BR; Westover L; Xu JZ; Look RA; Chen X; Beavers MP; Roberts J; Murray WV; Demarest KT; Kuo GH
Bioorg Med Chem; 2004 Mar; 12(5):1239-55. PubMed ID: 14980636
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and discovery of macrocyclic polyoxygenated bis-7-azaindolylmaleimides as a novel series of potent and highly selective glycogen synthase kinase-3beta inhibitors.
Kuo GH; Prouty C; DeAngelis A; Shen L; O'Neill DJ; Shah C; Connolly PJ; Murray WV; Conway BR; Cheung P; Westover L; Xu JZ; Look RA; Demarest KT; Emanuel S; Middleton SA; Jolliffe L; Beavers MP; Chen X
J Med Chem; 2003 Sep; 46(19):4021-31. PubMed ID: 12954055
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of novel 7-azaindolyl-heteroaryl-maleimides as potent and selective glycogen synthase kinase-3beta (GSK-3beta) inhibitors.
O'Neill DJ; Shen L; Prouty C; Conway BR; Westover L; Xu JZ; Zhang HC; Maryanoff BE; Murray WV; Demarest KT; Kuo GH
Bioorg Med Chem; 2004 Jun; 12(12):3167-85. PubMed ID: 15158785
[TBL] [Abstract][Full Text] [Related]
4. Macrocyclic bisindolylmaleimides as inhibitors of protein kinase C and glycogen synthase kinase-3.
Zhang HC; White KB; Ye H; McComsey DF; Derian CK; Addo MF; Andrade-Gordon P; Eckardt AJ; Conway BR; Westover L; Xu JZ; Look R; Demarest KT; Emanuel S; Maryanoff BE
Bioorg Med Chem Lett; 2003 Sep; 13(18):3049-53. PubMed ID: 12941331
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of 3-([1,2,4]triazolo[4,3-a]pyridin-3-yl)-4-(indol-3-yl)-maleimides as potent, selective GSK-3β inhibitors and neuroprotective agents.
Ye Q; Mao W; Zhou Y; Xu L; Li Q; Gao Y; Wang J; Li C; Xu Y; Xu Y; Liao H; Zhang L; Gao J; Li J; Pang T
Bioorg Med Chem; 2015 Mar; 23(5):1179-88. PubMed ID: 25662701
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel 4-azaindolyl-indolyl-maleimides as glycogen synthase kinase-3beta (GSK-3beta) inhibitors.
Ye Q; Xu G; Lv D; Cheng Z; Li J; Hu Y
Bioorg Med Chem; 2009 Jul; 17(13):4302-12. PubMed ID: 19481464
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and evaluation of 3-aryl-4-pyrrolyl-maleimides as glycogen synthase kinase-3β inhibitors.
Ye Q; Li M; Zhou YB; Cao JY; Xu L; Li YJ; Han L; Gao JR; Hu YZ; Li J
Arch Pharm (Weinheim); 2013 May; 346(5):349-58. PubMed ID: 23585245
[TBL] [Abstract][Full Text] [Related]
8. 3-(7-Azaindolyl)-4-arylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3.
Zhang HC; Ye H; Conway BR; Derian CK; Addo MF; Kuo GH; Hecker LR; Croll DR; Li J; Westover L; Xu JZ; Look R; Demarest KT; Andrade-Gordon P; Damiano BP; Maryanoff BE
Bioorg Med Chem Lett; 2004 Jun; 14(12):3245-50. PubMed ID: 15149684
[TBL] [Abstract][Full Text] [Related]
9. Discovery of potent and bioavailable GSK-3beta inhibitors.
Gong L; Hirschfeld D; Tan YC; Heather Hogg J; Peltz G; Avnur Z; Dunten P
Bioorg Med Chem Lett; 2010 Mar; 20(5):1693-6. PubMed ID: 20138512
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Evaluation of 3-(furo[2,3-b]pyridin-3-yl)-4-(1H-indol-3-yl)-maleimides as Novel GSK-3β Inhibitors and Anti-Ischemic Agents.
Ye Q; Li Q; Zhou Y; Xu L; Mao W; Gao Y; Li C; Xu Y; Xu Y; Liao H; Zhang L; Gao J; Li J; Pang T
Chem Biol Drug Des; 2015 Oct; 86(4):746-52. PubMed ID: 25711384
[TBL] [Abstract][Full Text] [Related]
11. 3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3).
Smith DG; Buffet M; Fenwick AE; Haigh D; Ife RJ; Saunders M; Slingsby BP; Stacey R; Ward RW
Bioorg Med Chem Lett; 2001 Mar; 11(5):635-9. PubMed ID: 11266159
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and evaluation of 7-azaindazolyl-indolyl-maleimides as glycogen synthase kinase-3β (GSK-3β) inhibitors.
Ye Q; Shen Y; Zhou Y; Lv D; Gao J; Li J; Hu Y
Eur J Med Chem; 2013 Oct; 68():361-71. PubMed ID: 23994329
[TBL] [Abstract][Full Text] [Related]
13. From a natural product lead to the identification of potent and selective benzofuran-3-yl-(indol-3-yl)maleimides as glycogen synthase kinase 3beta inhibitors that suppress proliferation and survival of pancreatic cancer cells.
Gaisina IN; Gallier F; Ougolkov AV; Kim KH; Kurome T; Guo S; Holzle D; Luchini DN; Blond SY; Billadeau DD; Kozikowski AP
J Med Chem; 2009 Apr; 52(7):1853-63. PubMed ID: 19338355
[TBL] [Abstract][Full Text] [Related]
14. Novel bis(indolyl)maleimide pyridinophanes that are potent, selective inhibitors of glycogen synthase kinase-3.
Zhang HC; Boñaga LV; Ye H; Derian CK; Damiano BP; Maryanoff BE
Bioorg Med Chem Lett; 2007 May; 17(10):2863-8. PubMed ID: 17350261
[TBL] [Abstract][Full Text] [Related]
15. Organometallic compounds with biological activity: a very selective and highly potent cellular inhibitor for glycogen synthase kinase 3.
Atilla-Gokcumen GE; Williams DS; Bregman H; Pagano N; Meggers E
Chembiochem; 2006 Sep; 7(9):1443-50. PubMed ID: 16858717
[TBL] [Abstract][Full Text] [Related]
16. 3D-QSAR and molecular docking studies on 3-anilino-4-arylmaleimide derivatives as glycogen synthase kinase-3β inhibitors.
Akhtar M; Bharatam PV
Chem Biol Drug Des; 2012 Apr; 79(4):560-71. PubMed ID: 22168279
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and structure-activity relationships of 1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3beta.
Saitoh M; Kunitomo J; Kimura E; Hayase Y; Kobayashi H; Uchiyama N; Kawamoto T; Tanaka T; Mol CD; Dougan DR; Textor GS; Snell GP; Itoh F
Bioorg Med Chem; 2009 Mar; 17(5):2017-29. PubMed ID: 19200745
[TBL] [Abstract][Full Text] [Related]
18. 3D-QSAR and molecular docking studies on pyrazolopyrimidine derivatives as glycogen synthase kinase-3beta inhibitors.
Dessalew N; Patel DS; Bharatam PV
J Mol Graph Model; 2007 Mar; 25(6):885-95. PubMed ID: 17018257
[TBL] [Abstract][Full Text] [Related]
19. Discovery and structural insight of a highly selective protein kinase inhibitor hit through click chemistry.
Gu G; Wang H; Liu P; Fu C; Li Z; Cao X; Li Y; Fang Q; Xu F; Shen J; Wang PG
Chem Commun (Camb); 2012 Mar; 48(22):2788-90. PubMed ID: 22314408
[TBL] [Abstract][Full Text] [Related]
20. Structure-based approaches in the design of GSK-3 selective inhibitors.
Patel DS; Dessalew N; Iqbal P; Bharatam PV
Curr Protein Pept Sci; 2007 Aug; 8(4):352-64. PubMed ID: 17696868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
